Cargando…
New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting
Immunotherapy has revolutionized cancer treatment, but currently, immuno-oncology agents have not been approved for patients with soft tissue sarcomas. However, there is growing evidence suggesting that immunotherapy could be an effective therapeutic strategy for this group of diseases. Here, we rev...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408188/ https://www.ncbi.nlm.nih.gov/pubmed/37553669 http://dx.doi.org/10.1186/s13045-023-01486-6 |